Stents

This channel includes news and new technology innovations for stents, also called vascular scaffolds. These include coronary stents, carotid stents, peripheral stents, bioresorbable or bioabsorbable stents, and renal stents. News included clinical trial data and new technology advances in stents.

Biotronik Astron stent
Technology | Stents Peripheral | December 31, 2015

December 31, 2015 - The U.S. Food and Drug Administration (FDA) has cleared Biotronik's Astron Peripheral Self-...

Technology | Stents Bare Metal | December 09, 2015

December 9, 2015 — Medinol U.S. recently opened their commercial business in Parsippany, New Jersey, followed by the...

Blog | Cath Lab | November 05, 2015

For the past few years, the focus of the annual Transcatheter Cardiovascular Therapeutics (TCT) meetings has been on...

Videos | TCT | November 05, 2015

DAIC Editor Dave Fornell offers his choices for the most innovative new interventional cardiovascular technologies...

Videos | TCT | November 05, 2015

Tom Watson, clinical analyst for MDBuyLine, and DAIC Dave Fornell discuss some of the technology trends at the 2015...

News | Stents Bioresorbable | October 30, 2015

October 30, 2015 — Results from a clinical trial showed that that the Abbott Absorb everolimus-eluting bioresorbable...

Videos | Stents Drug Eluting | October 30, 2015

Dr. Stephen Worthley, Ph.D., director of the cardiac cath labs at Royal Adelaide Hospital at the University of...

Videos | Stents Bioresorbable | October 30, 2015

Dean Kereiakes, M.D., medical director of The Christ Hospital Heart and Vascular Center, and a lead investigator for...

News | Stents Drug Eluting | October 27, 2015

October 27, 2015 — Results from the multicenter, prospective, randomized PANDA III trial indicate that the BuMA...

REMEDEE Registry, one-year outcomes, Combo dual therapy stent, OrbusNeich, TCT 2015
News | Stents Drug Eluting | October 26, 2015

October 26, 2015 — OrbusNeich announced the presentation of the one-year clinical outcomes from the 1,000-patient...

Medinol, BIONICS Trial, completes enrollment, eDES coronary stent system, elastomeric drug eluting stent

The eDES elastomer coating before and after expansion. Image courtesy of Medinol Inc.

News | Stents | October 26, 2015

October 26, 2015 — Medinol announced in September the completion of enrollment in its BIONICS trial to evaluate the...

TUXEDO trial, diabetic patients, drug-eluting stents, everolimus, paclitaxel, TCT 2015

Image courtesy of Abbott Vascular

News | Stents Drug Eluting | October 23, 2015

October 23, 2015 — Results of the ...

ISAR-DESIRE 4 trial, TCT 2015, drug-coated balloon, DCB, scoring balloon, SCB, drug-eluting stent restenosis

Image courtesy of Medtronic

Feature | Drug-Eluting Balloons | October 22, 2015

October 22, 2015 — Results from the ISAR-DESIRE 4 trial indicate that use of a scoring balloon plus a...

Amaranth Fortitute Bioresorbable stent

The Amaranth Fortitute bioresorbable stent was among several fully bioresorbing platforms discussed in sessions, late breaking trial data presentations and on the expo floor at TCT 2015.

Feature | TCT | October 19, 2015 | Tom Watson, BS, RCVT, Clinical Analyst, MD Buyline

There were several overarching technology trends seen at the 2015 Transcatheter Cardiovascular Therapeutics (TCT)...

Overlay Init